A 2019 study focused on the effect of BZW2 in colorectal cancer. It found that upregulation of BZW2 promoted tumor growth and had a downstream upregulation effect on c-Myc, a proto-oncogene. A second study from 2020 determined this upregulation also had a positive effect on the activation of the ERK/MAPK pathway.
